AVANDIA MKTG. SALES PRACTICES & PROD. LIAB. LITIG.

No. 14-1948.

804 F.3d 633 (2015)

In re AVANDIA MARKETING, SALES PRACTICES & PRODUCT LIABILITY LITIGATION GlaxoSmithKline, LLC, Appellant.

United States Court of Appeals, Third Circuit.

Opinion Filed: October 26, 2015.


Attorney(s) appearing for the Case

John H. Beisner, Esquire , (Argued), Skadden, Arps, Slate, Meagher & Flom, Washington, DC, Nina M. Gussack, Esquire , Anthony C. Vale, Esquire , Pepper & Hamilton, Philadelphia, PA, for Appellant.

Samuel Issacharoff, Esquire (Argued), New York, N.Y., James R. Dugan, II, Esquire , David B. Franco, Esquire , Douglas R. Plymale, Esquire , The Dugan Law Firm, New Orleans, LA, Arnold Levin, Esquire, Frederick S. Longer, Esquire , Levin, Fishbein, Sedran & Berman, Philadelphia, PA, for Appellees Allied Services Division Welfare Fund and UFCW Local 1776 and Participating Employees Health

Tracy D. Rezvani, Esquire , Rezvani Volin & Rotbert, Washington, DC, for Appellee United Benefit Fund.

Charles H. Moellenberg, Jr., Esq. , Jones Day, Pittsburgh, PA, Counsel for Amicus Appellant Product Liability Advisory Council.

Peter D. St. Phillip, Jr., Esq. , Lowey, Dannenberg, Cohen & Hart, White Plains, NY, for Amicus Appellees Aetna Inc, Louisiana Health Service Indemnity Co., Premera Blue Cross, Caring for Montanans Inc, Blue Cross & Blue Shield of Minnesota, CareFirst of Maryland Inc., Cambia Health Solutions, Highmark Inc., Emblem-Health Services Co., LLC, Group Health Cooperative, Blue Cross & Blue Shield of Rhode Island, Noridian Mutual Insurance Co., Health Net Inc., Government Employees Health Association, Blue Cross & Blue Shield of Florida, Blue Cross & Blue Shield of North Carolina, Wellpoint Inc., Blue Cross & Blue Shield of South Carolina, Blue Cross & Blue Shield of Massachusetts and AvMed Health Plans.

Robert N. Weiner, Esq. Arnold & Porter, Washington, DC, for Amicus Appellee Pharmaceuticals Research and Manufacturers of America.

Before: AMBRO, SCIRICA and ROTH, Circuit Judges.


OPINION

This interlocutory appeal involves claims brought against GlaxoSmithKline LLC (GSK) by third-party payors (TPPs), based on GSK's alleged misrepresentation and concealment of the significant safety risks associated with use of Avandia, Avandamet, and Avandaryl (collectively, Avandia), Type II diabetes drugs...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases